查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1968436

三尖瓣修復市場－全球產業規模、佔有率、趨勢、機會與預測：按適應症、最終用途、地區和競爭格局分類，2021-2031年

Tricuspid Valve Repair Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Indication, By End Use, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 182 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球三尖瓣修復市場預計將從 2025 年的 6.6369 億美元成長到 2031 年的 9.5796 億美元，複合年成長率達到 6.31%。

此領域涵蓋用於重建三尖瓣和糾正逆流而無需瓣膜置換的醫療設備和手術。市場成長的主要驅動力是老年人中心臟瓣膜疾病負擔的日益加重。例如，根據歐洲心臟學會 (ESC) 2024 年的預測，75 歲以上族群中將有 4% 患有相關的三尖瓣逆流。除了龐大的患者群體外，微創導管治療方法的日益普及（可縮短恢復時間）也極大地推動了市場發展。

市場概覽
預測期 2027-2031
市場規模：2025年 6.6369億美元
市場規模：2031年 9.5796億美元
複合年成長率：2026-2031年 6.31%
成長最快的細分市場 三尖瓣逆流
最大的市場 北美洲

然而，三尖瓣固有的複雜解剖結構給市場擴張帶來了巨大挑戰，因為這使得器械固定和介入治療過程中的可視化變得困難。克服這些挑戰需要先進的影像基礎設施和高度專業化的醫生培訓，而此類手術的實施通常僅限於大型學術機構。這些技術壁壘導致手術成本高昂，且在區域醫院的普及率較低，阻礙了市場擴張所需的廣泛應用。

市場促進因素

經導管三尖瓣修復術 (TTVR) 的技術進步正在重塑市場格局，為高風險手術提供了有效的替代方案。近期監管部門的核准表明，相關設備能夠有效應對三尖瓣複雜的解剖結構，從而推動了這項新治療方法的商業化。根據愛德華生命科學公司 (Edwards Life Sciences) 2024 年 2 月發布的新聞稿，該公司首次核准了此類經導管治療，使用 EVOQUE 系統治療的患者中，約 99% 的重度逆流被減輕至中度或更輕。這種臨床療效正推動著該療法的快速商業性化應用，愛德華生命科學公司 2024 年 10 月的報告顯示，經導管二尖瓣和三尖瓣治療的銷售額成長了 73%，達到 9,100 萬美元。

此外，三尖瓣逆流（TR）和心臟衰竭盛行率的上升凸顯了巨大的未滿足醫療需求。三尖瓣逆流常被稱為“被遺忘的瓣膜”，它廣泛影響老年患者群體，而由於手術風險，該群體歷來缺乏治療選擇。疾病負擔與介入率之間的差距是推動市場成長的關鍵因素。正如雅培公司在2024年4月宣布TriClip獲得FDA核准的新聞稿中所述，光是美國就有超過160萬人患有三尖瓣逆流。隨著先進的診斷技術識別出更多可能受益於這種新核准的微創治療的患者，市場將持續擴張，以滿足這一龐大的患者群體的需求。

市場挑戰

由於三尖瓣固有的複雜解剖結構，它對全球三尖瓣修復市場的成長構成了重大障礙。與其他心臟瓣膜不同，三尖瓣的結構高度可變，瓣葉脆弱，瓣環較大且不呈平面狀，通常有三個或更多瓣葉。這種複雜的結構使得修復裝置的固定極為困難，並且需要在手術過程中具備極佳的可視化能力。因此，有效的修復手術需要高度專業化的醫生培訓和先進的影像設備，例如術中經食道心臟超音波圖。這些嚴格的技術要求使得此類手術只能在大型大學醫院開展，阻礙了其在資源往往匱乏的地區性醫院的廣泛應用。

這種服務集中化造成了瓶頸，直接阻礙了市場成長。儘管瓣膜性心臟病發病率很高，但由於三尖瓣的解剖結構存在技術難題，手術數量相對於患者數量仍然非常低。根據2024年胸腔外科醫師協會（STS）的數據，單純三尖瓣手術仍有限，美國每年僅進行2,000多例。如此低的利用率表明，技術挑戰以及由此導致的手術專屬性阻礙了修復療法的廣泛普及和商業性擴充性。

市場趨勢

人工智慧增強多重模式影像技術的整合正迅速成為一項關鍵趨勢，直接解決了三尖瓣複雜解剖結構所帶來的視覺化難題。為了克服手術過程中的引導困難，製造商正在將人工智慧融入超音波心動圖系統，以實現影像識別和解剖結構量化的自動化。例如，西門子醫療在2024年8月的新聞稿中宣布，其新核准的ACUSON Origin系統已整合人工智慧輔助功能。該功能在場分類和多普勒定位方面達到了99%的準確率。這項技術進步降低了操作者差異，簡化了工作流程，有助於實現經導管修復所需的精準定位。

同時，關鍵臨床試驗和上市後註冊的加速推進，正在產生強力的長期證據，以支持修復通訊協定的標準化和更廣泛應用。隨著市場走出最初的可行性階段，大規模研究的成熟數據陸續發布，經導管緣對緣修復在不同真實世界患者群體中的持久性正得到證實。根據美國心臟學會於2024年8月發布的bRIGHT研究報告，雅培的TriClip系統展現持續的療效，一年後81%的患者三尖瓣逆流程度降至中度或輕度。這些積極的臨床結果在增強醫生信心和確保市場擴張所需的保險覆蓋方面發揮著至關重要的作用。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球三尖瓣修復市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 適應症（三尖瓣逆流、三尖瓣狹窄）
    • 依應用領域（醫院、門診手術中心（ASC）、其他）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美三尖瓣修復市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲三尖瓣修復市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區三尖瓣修復市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲三尖瓣修復市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲三尖瓣修復市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球三尖瓣修復市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Medtronic Plc
  • Edwards Lifesciences Corporation
  • LivaNova Plc
  • Abbott Laboratories Inc.
  • Corcym UK Limited
  • Micro Interventional Devices, Inc.
  • 4C Medical Technologies, Inc.
  • Venus Medtech（Hangzhou）Inc.
  • TRiCares GmbH
  • Trisol Medical

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 24064

The Global Tricuspid Valve Repair Market is projected to expand from USD 663.69 Million in 2025 to USD 957.96 Million by 2031, achieving a CAGR of 6.31%. This sector encompasses medical devices and procedural techniques designed to reconstruct the tricuspid valve and correct regurgitation without requiring replacement. Market growth is primarily fueled by the increasing burden of valvular heart disease among the geriatric population. For instance, the European Society of Cardiology estimated in 2024 that relevant tricuspid regurgitation affects 4% of individuals over the age of 75. This significant patient base, combined with a growing preference for minimally invasive transcatheter therapies that offer reduced recovery times, provides strong support for market development.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 663.69 Million
Market Size 2031USD 957.96 Million
CAGR 2026-20316.31%
Fastest Growing SegmentTricuspid Valve Regurgitation
Largest MarketNorth America

However, the inherent anatomical complexity of the tricuspid valve poses a substantial challenge to expansion, as it complicates device anchoring and visualization during interventions. Overcoming these difficulties requires advanced imaging infrastructure and highly specialized physician training, which often restricts the availability of these procedures to major academic centers. These technical barriers result in higher procedural costs and slower adoption rates in community hospital settings, thereby hindering the widespread accessibility necessary for broader market growth.

Market Driver

Technological advancements in Transcatheter Tricuspid Valve Repair (TTVR) are reshaping the market by offering viable alternatives to high-risk surgical procedures. Recent regulatory approvals have validated devices capable of addressing the complex anatomy of the tricuspid valve, enabling the commercialization of new therapies. According to an Edwards Lifesciences press release in February 2024 regarding the first FDA approval for such a transcatheter therapy, approximately 99 percent of patients treated with the EVOQUE system saw severe leakage reduced to moderate levels or less. This clinical efficacy is driving rapid commercial adoption, as evidenced by Edwards Lifesciences' October 2024 report, which showed a 73 percent increase in Transcatheter Mitral and Tricuspid Therapies sales to 91 million dollars.

Additionally, the rising prevalence of tricuspid regurgitation (TR) and heart failure highlights a massive unmet need. Often referred to as the "forgotten valve," TR affects a large geriatric patient population that has historically lacked treatment options due to surgical risks. This gap between disease burden and intervention rates serves as a critical catalyst for growth. As noted by Abbott in an April 2024 press release announcing FDA approval for TriClip, tricuspid regurgitation affects more than 1.6 million people in the U.S. alone. As advanced diagnostics identify more eligible candidates for these newly approved minimally invasive repairs, the market is expanding to accommodate this substantial patient pool.

Market Challenge

The inherent anatomical complexity of the tricuspid valve represents a significant barrier to the growth of the Global Tricuspid Valve Repair Market. Unlike other cardiac valves, the tricuspid valve features a highly variable structure with fragile leaflets and a large, non-planar annulus, often presenting with three or more leaflets. These intricacies significantly complicate the anchoring of repair devices and necessitate exceptional visualization capabilities during interventions. Consequently, effective repair procedures demand highly specialized physician training and advanced imaging infrastructure, such as intraprocedural transesophageal echocardiography. These stringent technical requirements effectively limit the availability of these procedures to major academic medical centers, preventing their widespread adoption in community hospitals where such resources may be scarce.

This concentration of service availability creates a bottleneck that directly impedes market growth. Despite the high prevalence of valvular disease, the technical difficulties associated with tricuspid anatomy result in procedural volumes that are disproportionately low relative to the patient population. Data from the Society of Thoracic Surgeons in 2024 indicates that isolated tricuspid valve surgeries remain limited, with just over 2,000 cases performed annually in the United States. This low utilization rate demonstrates how technical challenges and the resulting procedural exclusivity are stalling the broader accessibility and commercial scalability of repair therapies.

Market Trends

The integration of AI-enhanced multimodality imaging is rapidly emerging as a critical trend, directly addressing the visualization challenges associated with the complex anatomy of the tricuspid valve. To overcome the difficulties of intra-procedural guidance, manufacturers are embedding artificial intelligence into echocardiography systems to automate view recognition and anatomical quantification. For example, Siemens Healthineers announced in an August 2024 press release that their newly cleared ACUSON Origin system features AI Assist capabilities, demonstrating a 99 percent accuracy rate for view classification and Doppler placement. This technological advancement reduces operator variability and streamlines workflow, thereby facilitating the precise anchoring required for effective transcatheter repair.

Concurrently, the acceleration of pivotal clinical trials and post-market registries is generating the robust long-term evidence needed to standardize repair protocols and support wider adoption. As the market moves beyond early feasibility stages, the release of mature data from large-scale studies is validating the durability of transcatheter edge-to-edge repair in diverse, real-world patient populations. According to an August 2024 report from the American College of Cardiology regarding the bRIGHT study, the Abbott TriClip system demonstrated sustained efficacy, with 81 percent of patients achieving tricuspid regurgitation of moderate or less at one year. These positive clinical outcomes are instrumental in building physician confidence and securing the reimbursement necessary for market expansion.

Key Market Players

  • Medtronic Plc
  • Edwards Lifesciences Corporation
  • LivaNova Plc
  • Abbott Laboratories Inc.
  • Corcym UK Limited
  • Micro Interventional Devices, Inc.
  • 4C Medical Technologies, Inc.
  • Venus Medtech (Hangzhou) Inc.
  • TRiCares GmbH
  • Trisol Medical

Report Scope

In this report, the Global Tricuspid Valve Repair Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Tricuspid Valve Repair Market, By Indication

  • Tricuspid Valve Regurgitation
  • Tricuspid Valve Stenosis

Tricuspid Valve Repair Market, By End Use

  • Hospitals
  • Ambulatory Surgical Centers {ASCs}
  • Others

Tricuspid Valve Repair Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Tricuspid Valve Repair Market.

Available Customizations:

Global Tricuspid Valve Repair Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Tricuspid Valve Repair Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Indication (Tricuspid Valve Regurgitation, Tricuspid Valve Stenosis)
    • 5.2.2. By End Use (Hospitals, Ambulatory Surgical Centers {ASCs}, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Tricuspid Valve Repair Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Indication
    • 6.2.2. By End Use
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Tricuspid Valve Repair Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Indication
        • 6.3.1.2.2. By End Use
    • 6.3.2. Canada Tricuspid Valve Repair Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Indication
        • 6.3.2.2.2. By End Use
    • 6.3.3. Mexico Tricuspid Valve Repair Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Indication
        • 6.3.3.2.2. By End Use

7. Europe Tricuspid Valve Repair Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Indication
    • 7.2.2. By End Use
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Tricuspid Valve Repair Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Indication
        • 7.3.1.2.2. By End Use
    • 7.3.2. France Tricuspid Valve Repair Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Indication
        • 7.3.2.2.2. By End Use
    • 7.3.3. United Kingdom Tricuspid Valve Repair Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Indication
        • 7.3.3.2.2. By End Use
    • 7.3.4. Italy Tricuspid Valve Repair Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Indication
        • 7.3.4.2.2. By End Use
    • 7.3.5. Spain Tricuspid Valve Repair Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Indication
        • 7.3.5.2.2. By End Use

8. Asia Pacific Tricuspid Valve Repair Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Indication
    • 8.2.2. By End Use
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Tricuspid Valve Repair Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Indication
        • 8.3.1.2.2. By End Use
    • 8.3.2. India Tricuspid Valve Repair Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Indication
        • 8.3.2.2.2. By End Use
    • 8.3.3. Japan Tricuspid Valve Repair Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Indication
        • 8.3.3.2.2. By End Use
    • 8.3.4. South Korea Tricuspid Valve Repair Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Indication
        • 8.3.4.2.2. By End Use
    • 8.3.5. Australia Tricuspid Valve Repair Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Indication
        • 8.3.5.2.2. By End Use

9. Middle East & Africa Tricuspid Valve Repair Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Indication
    • 9.2.2. By End Use
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Tricuspid Valve Repair Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Indication
        • 9.3.1.2.2. By End Use
    • 9.3.2. UAE Tricuspid Valve Repair Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Indication
        • 9.3.2.2.2. By End Use
    • 9.3.3. South Africa Tricuspid Valve Repair Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Indication
        • 9.3.3.2.2. By End Use

10. South America Tricuspid Valve Repair Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Indication
    • 10.2.2. By End Use
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Tricuspid Valve Repair Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Indication
        • 10.3.1.2.2. By End Use
    • 10.3.2. Colombia Tricuspid Valve Repair Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Indication
        • 10.3.2.2.2. By End Use
    • 10.3.3. Argentina Tricuspid Valve Repair Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Indication
        • 10.3.3.2.2. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Tricuspid Valve Repair Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Medtronic Plc
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Edwards Lifesciences Corporation
  • 15.3. LivaNova Plc
  • 15.4. Abbott Laboratories Inc.
  • 15.5. Corcym UK Limited
  • 15.6. Micro Interventional Devices, Inc.
  • 15.7. 4C Medical Technologies, Inc.
  • 15.8. Venus Medtech (Hangzhou) Inc.
  • 15.9. TRiCares GmbH
  • 15.10. Trisol Medical

16. Strategic Recommendations

17. About Us & Disclaimer